Taimei Technology, Inc.

Guided by the vision of "Making health accessible through the power of digital intelligence," Taimei Technology (02576.HK) is a digital-intelligent platform serving the life sciences industry across pharmaceutical R&D, pharmacovigilance, and commercialization. Through its independently developed portfolio of SaaS solutions, AI agents, and endpoint assessment services, the company greatly enhances the efficiency and quality of drug development.

Today, Taimei Technology has established three major data and delivery centers in China, the U.S., and Singapore, serving more than 1,400 pharmaceutical companies and CROs worldwide.